Among adolescents, the researchers noted that the number who were dispensed exenatide, liraglutide or dulaglutide was greatest throughout the study period and increased steadily, whereas the number who were dispensed injectable semaglutide for weight management increased in 2023
While access remains uneven across commercial plans and Medicare coverage for obesity medicines is still limited, CVS decision signals continued normalization of GLP-1 therapies within mainstream pharmacy benefit design and intensifies competition between Lilly and Novo Nordisk for long-term market leadership in obesity careTop of FormBottom of Form Sources CVS brings back coverage for Lilly's obesity drug Zepbound Reuters May 28, 2026 Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge Reuters May 1, 2025
That conclusion does not require overstating the evidence
Details Product Information About brand: 9wishes Korean beauty brand 9wishes takes its name from the auspicious number 9, which alludes to perfection in Korean culture
Step-by-Step Process to Secure Coverage 1
Gilead gains Hepcludex (bulevirtide), which was conditionally approved by the European Medicines Agency for the treatment of chronic HDV infection in adults with compensated liver disease in July 2020